tiprankstipranks

Priya Singhal Insider Profile

4 Followers
Priya Singhal, Head of Research & Development at Larimar Therapeutics, holds ― shares in Larimar Therapeutics (Ticker: LRMR), holds 4.89K shares in Biogen (Ticker: BIIB). Most recently, Priya Singhal ― shares of Larimar Therapeutics on ― for an estimated value of ―.
tipranks
Priya Singhal

Priya Singhal
Larimar Therapeutics (LRMR)
Head of Research & Development

Not Ranked
Priya Singhal has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$939K
100.00%
0.00%
A breakdown of Priya Singhal's holdings

Insider Roles

Biogen
(BIIB)
Head of Development
Larimar Therapeutics
(LRMR)
Head of Research & Development
Roles that Priya Singhal holds in companies

Most Profitable Insider Trade

Stock:
Biogen
(BIIB)
Rating:Informative Sell
Date:Feb 26, 2024 - Today
Return:+11.40%
The most profitable trade made by Priya Singhal

Priya Singhal's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Larimar Therapeutics
Head of Research & Development
Biogen
Apr 03, 2024
Head of Development
Uninformative Sell
19.82K
$938.89K
List of latest transactions for each holding click on a transaction to see Priya Singhal's performance on stock

Priya Singhal insider profile FAQ

What is the percentage of profitable transactions made by Priya Singhal?
The percentage of profitable transactions made by Priya Singhal is ―.
    What is the average return per transaction made by Priya Singhal?
    The average return per transaction made by Priya Singhal is ―.
      What stocks does Priya Singhal hold?
      Priya Singhal holds: LRMR, BIIB stocks.
        What was Priya Singhal’s latest transaction?
        Priya Singhal latest transaction was an Uninformative Buy of ―.
          What was Priya Singhal's most profitable transaction?
          Priya Singhal’s most profitable transaction was an Informative Sell of BIIB stock on February 26, 2024. The return on the trade was 11.40%.
            What is Priya Singhal's role in Larimar Therapeutics?
            Priya Singhal's role in Larimar Therapeutics is Head of Research & Development.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.